Polar Capital Holdings PLC Exelixis, Inc. Transaction History

Polar Capital Holdings PLC

$16.3 Billion
Q3 2024

A detailed history of Polar Capital Holdings PLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Polar Capital Holdings PLC holds 200,000 shares of EXEL stock, worth $6.94 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

200,000

Previous 200,000 -0.0%

Holding current value

$6.94 Million

Previous $4.49 Million 15.49%

% of portfolio

0.03%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $2.09 Million - $2.43 Million	-102,606 Reduced 33.91%	200,000 $4.49 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $14.7 Million - $18.4 Million	-764,040 Reduced 71.63%	302,606 $7.26 Million
Q3 2023 Nov 14, 2023	SELL	$19.04 - $22.74 $42.9 Million - $51.3 Million	-2,254,252 Reduced 67.88%	1,066,646 $23.3 Million
Q1 2023 Dec 13, 2023	BUY	$16.3 - $19.41 $36.7 Million - $43.8 Million	2,254,252 Added 211.34%	3,320,898 $64.5 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $12.2 Million - $14.6 Million	750,000 Added 29.17%	3,320,898 $64.5 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $8.91 Million - $10.4 Million	595,624 Added 30.15%	2,570,898 $41.2 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $5.24 Million - $7.44 Million	-334,025 Reduced 14.46%	1,975,274 $31 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $892,021 - $1.18 Million	-51,148 Reduced 2.17%	2,309,299 $48.1 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $34.8 Million - $46.3 Million	-2,041,700 Reduced 46.38%	2,360,447 $53.5 Million
Q4 2021 Feb 14, 2022	BUY	$15.84 - $21.88 $5.23 Million - $7.22 Million	330,179 Added 8.11%	4,402,147 $80.5 Million
Q3 2021 Nov 15, 2021	BUY	$16.3 - $21.14 $19.7 Million - $25.5 Million	1,205,726 Added 42.07%	4,071,968 $86.1 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $5.44 Million - $7.74 Million	302,955 Added 11.82%	2,866,242 $52.2 Million
Q1 2021 May 17, 2021	BUY	$20.53 - $25.22 $5.13 Million - $6.31 Million	250,000 Added 10.81%	2,563,287 $57.9 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $42.5 Million - $57.4 Million	2,313,287 New	2,313,287 $46.4 Million

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.2B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Polar Capital Holdings PLC with notifications on news.

Account

Polar Capital Holdings PLC Exelixis, Inc. Transaction History